Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...
Hoth Therapeutics (HOTH) announced preclinical findings that highlight the potential of Glial Cell Line-Derived Neurotrophic Factor, or GDNF, ...
AZoLifeSciences on MSN8d
Minoryx Announces Dosing of the First Patient with Leriglitazone in the Phase 2a Study in Rett Syndrome (TREE Study)Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback